摘要
目的:探讨选择性环氧合酶-2抑制剂塞来昔布对大鼠胃肿瘤发生的预防作用。方法:取SD大鼠100只,除20只为正常对照组外,其余80只大鼠以苯并芘灌胃造模,4周后将大鼠随机均分成模型对照组和塞来昔布大、中、小剂量(15、10、5mg·kg-1)组;正常对照组及模型对照组喂养普通饲料,塞来昔布组喂养相应的含药饲料,分别于10周和21周时观察各组大鼠胃肿瘤发生率、肿瘤发生数量和肿瘤体积。结果:与模型对照组比较,塞来昔布中、大剂量组肿瘤发生率和发生数量较低(P<0.01或P<0.05),肿瘤体积无明显差异。结论:塞来昔布具有抑制大鼠胃肿瘤发生的作用。
OBJECTIVE: To investigate the preventive effect of celecoxib, a selective cyclooxygenase (COX) - 2 inhibitor, on stomach tumor in rats. METHODS: A total of 100 SD rats were randomly divided into 2 groups: of which, 20 served as normal control, another 80 were intragastrically administrated with benzo pyrene to induce stomach tumor. Four weeks later, the model rats were randomly divided into 4 groups: model control group and celecoxib high, medium and low dosage( 15,10,5 mg· kg^-1) groups. The normal control group and model control group were fed with common feedstuff, while celecoxib groups with corresponding drug - containing feedstuff. The incidence, number and size of stomach tumors were recorded at 10 and 21 weeks, respectively. RESULTS: As compared with the model control group, the incidence and number of stomach tumors in celecoxib groups (medium and high dosage) were lower (P 〈 0.01 or P 〈 0.05), however, the difference in tumor size was not significant. CONCLUSION: Celecoxib has inhibition on the incidence of stomach tumor in rats.
出处
《中国药房》
CAS
CSCD
北大核心
2009年第28期2177-2179,共3页
China Pharmacy
基金
河北省2008年医学科学研究重点课题计划(08392)